Abstract
Objectives Heart failure with preserved ejection fraction (HFpEF) has a high hospitalization rate. While recent guidelines recommend specific parameters like E/e’, e’ velocity, and left atrial volume index (LAVI) for diagnosing HFpEF, their clinical accuracy remains limited. Left atrial (LA) strain has emerged as a potential diagnostic parameter, yet its role in the Vietnamese population is unclear. This study aims to evaluate LA strain’s diagnostic role in HFpEF among Vietnamese patients, exploring its relationship with established parameters of left ventricle (LV) diastolic function to determine its potential utility as a diagnostic tool.
Methods A cross-sectional study was conducted from 15/04/2022 to 01/12/2023, involving 118 subjects, including 49 patients with HFpEF and 69 individuals without cardiac dysfunction. The study subjects were evaluated for LA strain and HFA-PEFF score. Diagnostic criteria for HFpEF were based on the 2021 European Society of Cardiology guidelines for diagnosing and treating acute and chronic heart failure.
Results LA strain including LA reservoir (LASr), conduit (LAScd), and contractile (LASct) functions, in the HFpEF group were 20.80% [26.50 - 13.30], 9.08 ± 6.18%, and 10.89 ± 5.16%, respectively. The control group had corresponding LASr, LAScd, and LASct values of 34.45% [38.07 - 31.14], 17.33 ± 5.72%, and 17.38 ± 4.41% (p < 0.001). The area under the curve (AUC) for LASr, LAScd, LAScr, HFA-PEFF score, LAVI, and GLS to diagnose HFpEF was 0.852, 0.770, 0.778, 0.890, 0.615, and 0.701, respectively. Comparing the AUCs for diagnosing HFpEF between LASr and HFA-PEFF score, no difference was found with p = 0.419.
Conclusion LA strain has a diagnostic value equivalent to the HFA-PEFF score in diagnosing HFpEF. These indices could be incorporated into the existing guidelines to enhance the diagnosis of HFpEF.
Strengths and limitations of this study
The study provides valuable data specific to the Vietnamese population, enhancing the understanding of heart failure with preserved ejection fraction and potentially leading to more tailored diagnostic strategies and treatments.
This study directly evaluates two diagnostic tools by comparing left atrial strain with the HFA-PEFF score, which can help clinicians choose the most appropriate method for diagnosing HFpEF in clinical practice.
The inclusion of left atrial strain as a diagnostic metric is relatively novel. It may provide new insights into the pathophysiology of HFpEF, offering a potential alternative or complement to existing diagnostic criteria.
The findings can have immediate clinical implications, potentially improving the accuracy of HFpEF diagnosis and leading to better patient outcomes through more precise treatment plans.
Our study has limitations, such as a relatively small sample size, sole location, and technical constraints. Addressing these limitations through further research will enhance the robustness and applicability of the findings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was not funded by any specific grant from public, commercial, or not-for-profit organizations.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study received approval from The Institutional Ethics Committee of Hue University of Medicine and Pharmacy (Approval number: H2022/034).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
In this version of the manuscript, we have made several significant updates. We have updated the profiles of the authors and improved the presentation of tables and charts to enhance readability. Additionally, we have made improvements to the grammar and writing style for better clarity and coherence. Furthermore, we have reviewed and corrected a few minor errors in the data to ensure accuracy.
Data Availability
Data cannot be shared publicly due to certain local ethical constraints. Researchers who meet the criteria for access to confidential data may contact the author, Hai Nguyen Ngoc Dang (via email at ngochai123dc{at}gmail.com).
https://academic.oup.com/eurheartj/article/40/40/3297/5557740?login=false